APCOM and IDPC urge the public, law enforcement, and policymakers in Thailand to help ensure equality and equity for LGBTQ+ people who use drugs, especially in their access to health and social services, and ending stigma and discrimination against them.
UNODC releases its annual analysis of global drug markets, trends, and policy developments – which includes, for the first time, a chapter on the right to health and drug use.
The HIV Legal Network identifies what can and needs to be done to strengthen the response to HIV, other STBBIs, and other health concerns among GBT2Q people who use drugs.
The EMCDDA reports on high availability and potency of substances, increasingly sophisticated supply infrastructures and the involvement and exploitation of people in situations of vulnerability in informal markets.
The Parabola Center finds that most Americans prioritise social equity in cannabis regulation, trusting communities with lived-experience and people who use marijuana to craft fair cannabis policy.
Fonseca et al. document no difference on cognitive function between non-users and long-term drinkers of ayahuasca, a substance with psychedelic properties.
IDPC recommends improving data collection, prioritising health-based responses, reviewing drug policy frameworks and ensuring robust civil society engagement.
UNAIDS Ghana and IDPC bring together key actors to identify priorities for tackling stigma surrounding people who use drugs, including education, training, and policy reform.
UNAIDS and UNDP offer guidance to assist in preparing for crises, suggest principles and actions, propose coordinated responses, and advocate for long-lasting initiatives to prevent future crises.
HRI highlight that the global movement for abolition of the death penalty continues to gain ground, yet progress related to drug offences specifically remains a persistent fight.
